Add-on SGLT2 inhibitors to ACE inhibitors enhance cardiorenal protection: Circulation Medha Baranwal28 July 2022 10:00 AM ISTCanada: The addition of sodium-glucose cotransporter 2 inhibitor treatment to angiotensin-converting enzyme inhibitor leads to suppression of...
Add on Empagliflozin to automated insulin delivery improves glycemic control in type 1 diabetes Dr. Hiral patel19 July 2022 11:00 AM ISTUSA: A new study showed that the use of empagliflozin as an adjunct to automated insulin delivery (AID) improved glycemic management in adults with...
Vitamin D Supplementation May Offset Bone Loss Caused by canagliflozin Dr. Kamal Kant Kohli28 Jun 2022 11:00 AM ISTSGLT2 inhibitors have been shown to slow the progression of diabetes-related kidney disease and is increasingly being considered as a first-line...
Important Updates to the Standards of Medical Care in Diabetes-2022 Incorporate New Evidence Dr. Kamal Kant Kohli13 Jun 2022 9:15 AM ISTToday, the American Diabetes Association (ADA) published important updates to the Standards of Medical Care in Diabetes-2022 (Standards of Care), in...
SGLT2 Inhibitors Reduce Hyperkalemia in High-Risk T2DM Patients MD Bureau3 May 2022 10:00 AM ISTHyperkalemia can occur in people with type 2 diabetes, especially in those with chronic kidney disease (CKD), and is clinically important because it...
Addition of incretin-based drugs better than 'switching' in cases of SGLT2 inhibitor failure, study says Medha Baranwal14 April 2022 10:00 AM ISTChina: The addition of incretin-based drugs for adults with type-2 diabetes not well controlled with sodium-glucose cotransporter-2 inhibitors...
Early Initiation of SGLT2 inhibitors Benefits Heart Failure Patients MD Bureau13 April 2022 11:00 AM ISTHeart failure (HF) is a growing public health issue. The increasing burden of HF on health care is primarily due to an ageing population, as evidenced...
Early initiation of Empagliflozin Improves QoL in Acute HF Patients within 2 weeks: EMPULSE Trial MD Bureau9 April 2022 10:30 AM ISTIntroduction Patients hospitalized for acute heart failure (AHF) are at high risk for cardiovascular death and readmission, and also experience an...
Insulin Glargine Induces Less Insulin Antibody Than Other Insulin Regimens MD Bureau11 March 2022 10:00 AM ISTInsulin antibodies (IAs), which were found commonly developed in patients treated with exogenous insulin, might affect glycemic control due to their...
SGLT2 inhibitors use tied to lower pneumonia risk in diabetics: Study Medha Baranwal30 Dec 2021 9:30 AM ISTChina: Patients with type 2 diabetes using SGLT2 inhibitors are at a significantly lower risk of pneumonia and pneumonia mortality versus those using...
SGLT2 inhibitors use not tied to significant risk of amputations in diabetics: Study Medha Baranwal29 Dec 2021 9:00 AM ISTSingapore: A meta-analysis of 15 randomized controlled trials of SGLT2 inhibitors for diabetes and non-diabetes patients, showed no significant...
SGLT2 inhibitors may lower anemia risk in diabetes patients, study finds Medha Baranwal26 Nov 2021 11:00 AM ISTJapan: The use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) is associated with higher levels of hemoglobin and lower anemia prevalence in...
